Indegene: Board Approves Q2 FY27 Results, Notes Director Resignations

Indegene Limited’s Board of Directors convened on October 29, 2026, approving the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The meeting also accepted the resignations of two key individuals: Mr. Mark Francis Dzialga from the Board and Ms. Srishti Ramesh Kaushik from her roles as Company Secretary and Compliance Officer. The board also approved amendments to the company’s Sexual Harassment Policy and noted the re-constitution of its committees.

Indegene Board Meeting Outcomes

On October 29, 2026, the Board of Directors of Indegene Limited held a meeting where several key decisions were made and noted. The primary outcomes included the approval of the unaudited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2026. These results were accompanied by a Limited Review Report from the auditors, which carried an unmodified opinion.

Key Personnel Changes Noted

The Board formally accepted the resignation of Mr. Mark Francis Dzialga from his position as Non-Executive – Non-Independent Director, effective from the close of business hours on October 29, 2026. The Board expressed appreciation for his valuable contributions. Concurrently, the composition of the Nomination and Remuneration Committee and the Investment Committee was re-constituted following Mr. Dzialga’s departure.

Additionally, the resignation of Ms. Srishti Ramesh Kaushik from her roles as Company Secretary, Compliance Officer, and Key Managerial Personnel was noted and accepted. Ms. Kaushik will be relieved from her duties on December 02, 2026. The Board also recorded its appreciation for her services.

Other Approvals and Information

The Board also approved allotments under the RSU Scheme 2020 and ESOP Scheme 2020. Furthermore, an amendment to the Prevention of Sexual Harassment Policy of the Company was approved. The company also informed that the Trading Window for dealing in securities would reopen on November 02, 2026.

The board meeting commenced at 06:30 PM (IST) and concluded at 07:16 PM (IST). Detailed financials and other relevant information are provided in the enclosed annexures.

Source: BSE

Previous Article

P N Gadgil Jewellers: Q2 FY27 Revenue Climbs 22.4% to ₹26,663.8 Mn

Next Article

Intellect Design Arena: Grants 1.83 Lakh RSUs to 19 Associates